NASDAQ:MDSO

Medidata Solutions Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

$92.22

0.00 (0.00 %)

(As of 10/28/2019)

Add

Compare

Today's Range

$92.21

▼

$92.26

50-Day Range

$91.79

▼

$92.25

52-Week Range

$60.10

▼

$98.60

Volume7.30 million shs

Average Volume1.24 million shs

Market Capitalization$5.76 billion

P/E Ratio96.06

Dividend YieldN/A

Beta1.22

Receive MDSO News and Ratings via Email

Sign-up to receive the latest news and ratings for Medidata Solutions and its competitors with MarketBeat's FREE daily newsletter.

About Medidata Solutions

Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company was founded in 1999 and is headquartered in New York, New York.

Medidata Becomes First Company to Offer End-to-End, Unified, Secure Platform for Decentralization of Clinical Trials (DCT)
June 15, 2021 | ca.finance.yahoo.com

Medidata Launches myMedidata Registries to Transform Awareness, Access, and Retention of Patients in Clinical Trials
June 8, 2021 | nz.finance.yahoo.com

Medidata Launches New Functionality to Enable Holistic Risk-Based Quality Management for Clinical Trials
April 12, 2021 | finance.yahoo.com

Insight Clinical Consulting Becomes a Medidata Rave EDC Accredited Partner
April 6, 2021 | finance.yahoo.com

Medidata Acorn AI Supports EUSA Pharma’s Relaunch of SYLVANT® in the US Market
March 24, 2021 | finance.yahoo.com

Medidata Thought Leaders Discuss the Future of Clinical Trials at 2021 SCOPE Annual Meeting
March 1, 2021 | businesswire.com

Horizon Therapeutics plc Expands Medidata Partnership to Further Enhance Clinical Trial Efficiencies and Outcomes
February 4, 2021 | businesswire.com

Phreesia Announces Planned CFO Transition in 2021: Chief Financial Officer Tom Altier to Retire, Randy Rasmussen Named New CFO
December 8, 2020 | benzinga.com

Medidata Acquires Digital Biomarker Business of MC10, Enhancing Remote Biometric Data Capture Capabilities in Hybrid and Virtual Clinical Trials
October 28, 2020 | businesswire.com

The Patient Equation, a New Book by Medidata co-CEO Glen de Vries, Explores How the Digital Revolution Is Making Precision Medicine a Reality
September 16, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Prepackaged software
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:MDSO
Previous Symbol
CUSIP58471A10
CIK1453814
Webwww.mdsol.com
Phone212-918-1800
Employees1,998
Year FoundedN/A

Sales & Book Value

Annual Sales$635.70 million
Price / Sales9.06
Cash Flow$1.69 per share
Price / Cash Flow54.55
Book Value$10.32 per share
Price / Book8.94

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares62,460,000
Market Cap$5.76 billion
Next Earnings DateN/A
OptionableOptionable

MarketRank^™

Overall MarketRank^™

1.25 out of 5 stars

Medical Sector

916th out of 2,105 stocks

Prepackaged Software Industry

143rd out of 312 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Medidata Solutions.

2.7 Community Rank

Outperform Votes
Medidata Solutions has received 506 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Medidata Solutions has received 423 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Medidata Solutions has received 54.47% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote “Outperform” if you believe MDSO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Medidata Solutions does not currently pay a dividend.
Dividend Growth
Medidata Solutions does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Medidata Solutions insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.70% of the stock of Medidata Solutions is held by insiders.
Percentage Held by Institutions
93.30% of the stock of Medidata Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Medidata Solutions are expected to grow by 29.49% in the coming year, from $0.78 to $1.01 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Medidata Solutions is 96.06, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.45.
Price to Earnings Ratio vs. Sector
The P/E ratio of Medidata Solutions is 96.06, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 43.66.
Price to Earnings Growth Ratio
Medidata Solutions has a PEG Ratio of 6.95. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Medidata Solutions has a P/B Ratio of 8.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions

What stocks does MarketBeat like better than Medidata Solutions?

Wall Street analysts have given Medidata Solutions a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medidata Solutions wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Medidata Solutions' earnings last quarter?

Medidata Solutions Inc (NASDAQ:MDSO) issued its earnings results on Monday, July, 22nd. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.31. The business had revenue of $180.50 million for the quarter, compared to analyst estimates of $179.95 million. Medidata Solutions had a net margin of 6.43% and a trailing twelve-month return on equity of 8.64%. The company's revenue for the quarter was up 15.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.43 EPS.
View Medidata Solutions' earnings history.

Who are Medidata Solutions' key executives?

Medidata Solutions' management team includes the following people:

Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 57)
Mr. Glen M. de Vries, Co-Founder, Pres & Director (Age 47)
Mr. Rouven Bergmann, Chief Financial Officer (Age 46)
Mr. Michael Pray, Exec. VP - Gen. Mang. of Global Sales (Age 53)
Ms. Jill Larsen, Exec. VP - HR & Chief HR Officer (Age 46)

Who are some of Medidata Solutions' key competitors?

Some companies that are related to Medidata Solutions include Cerner (CERN), Omnicell (OMCL), Allscripts Healthcare Solutions (MDRX), Cortexyme (CRTX), Vocera Communications (VCRA), HealthStream (HSTM), Computer Programs and Systems (CPSI), Athena Technology Acquisition (ATHN) and Mirage Energy (MRGE).
View all of MDSO's competitors.

What other stocks do shareholders of Medidata Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), salesforce.com (CRM), Gilead Sciences (GILD), Allergan (AGN), Alibaba Group (BABA), Grubhub (GRUB), International Business Machines (IBM), Western Digital (WDC) and BioMarin Pharmaceutical (BMRN).

What is Medidata Solutions' stock symbol?

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

What is Medidata Solutions' stock price today?

One share of MDSO stock can currently be purchased for approximately $92.22.

How much money does Medidata Solutions make?

Medidata Solutions has a market capitalization of $5.76 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis.

How many employees does Medidata Solutions have?

Medidata Solutions employs 1,998 workers across the globe.

What is Medidata Solutions' official website?

The official website for Medidata Solutions is www.mdsol.com.

Where are Medidata Solutions' headquarters?

Medidata Solutions is headquartered at 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014.

How can I contact Medidata Solutions?

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]

This page was last updated on 6/22/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Medidata Solutions Stock Forecast, Price & News

About Medidata Solutions

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

2.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

1.7 Company Ownership

1.9 Earnings and Valuation

Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions

What stocks does MarketBeat like better than Medidata Solutions?

How were Medidata Solutions' earnings last quarter?

Who are Medidata Solutions' key executives?

Who are some of Medidata Solutions' key competitors?

What other stocks do shareholders of Medidata Solutions own?

What is Medidata Solutions' stock symbol?

What is Medidata Solutions' stock price today?

How much money does Medidata Solutions make?

How many employees does Medidata Solutions have?

What is Medidata Solutions' official website?

Where are Medidata Solutions' headquarters?

How can I contact Medidata Solutions?

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

MarketRank^™

Overall MarketRank^™